Home / Dr. Sonia Vallet

Dr. Sonia Vallet

Forschungsteam "Signal Transduction and the Tumor Microenvironment"

Vallet Sonia

Publikationen

  1. 2019

    • Zeitschriftenartikel

      • Li, S., Vallet S., Sacco A., Roccaro A., Lentzsch S., & Podar K.
        (2019).  Targeting transcription factors in multiple myeloma: evolving therapeutic strategies.
        Expert Opin Investig Drugs. 28, 445-462.

      • Vallet, S., Fan F., Malvestiti S., Pecherstorfer M., Sattler M., Schneeweiss A., et al.
        (2019).  Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
        Breast Cancer Res Treat. 173, 585-596.

  2. 2018

    • Zeitschriftenartikel

      • Vallet, S., Fan F., Malvestiti S., Pecherstorfer M., Sattler M., Schneeweiss A., et al.
        (2018).  Rationally derived drug combinations with the novel Mcl-1 inhibitor EU-5346 in breast cancer.
        Breast Cancer Research and Treatment.

      • Vallet, S., Filzmoser J. M., Pecherstorfer M., & Podar K.
        (2018).  Myeloma Bone Disease: Update on Pathogenesis and Novel Treatment Strategies.
        Pharmaceutics. 10, 202.

      • Vallet, S., Hoyle N. R., Kyle R. A., Podar K., & Pecherstorfer M.
        (2018).  A role for bone turnover markers beta-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
        Leukemia & Lymphoma. 59, 2431-2438.

  3. 2017

    • Zeitschriftenartikel

      • Fan, F., Bashari M. H., Morelli E., Tonon G., Malvestiti S., Vallet S., et al.
        (2017).  The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.
        Leukemia. 31, 1570-1581.

      • Rosenberger, F., Wiskemann J., Vallet S., Haag G. M., Schembri E., Jager D., et al.
        (2017).  Resistance training as supportive measure in advanced cancer patients undergoing TKI therapy-a controlled feasibility trial.
        Support Care Cancer. 25, 3655-3664.

      • Vallet, S., Pecherstorfer M., & Podar K.
        (2017).  Adoptive cell therapy in multiple Myeloma.
        Expert Opinion on Biological Therapy. 17, 1511-1522.

Events

  1. 25 Okt

    1. NÖ Krebsinformationstag

    25. Oktober 2019, 09:00 - 17:00
    Karl Landsteiner Privatuniversität, Trakt Y
  2. 06 Nov

    Hearing Gerontologie

    06. November 2019, 10:30 - 12:00
    Karl Landsteiner Privatuniversität, Trakt Y, 4.Stock, Skylounge
  3. 16 Nov

    Tag der offenen Tür - November 2019

    16. November 2019, 10:00 - 14:00
    Karl Landsteiner Privatuniversität, Dr.-Karl-Dorrek-Straße 30,3500 Krems, Trakt Y, Erdgeschoß